RxSight, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

RxSight, Inc. reported Cash And Cash Equivalents At Carrying Value of $19.95 million for the year ending 2025.

  • RxSight, Inc. showed an increase of +19.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from RxSight, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), RxSight, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 42.6%.
  • Historical annual values: Fiscal year 2025: $19.95 million | Fiscal year 2024: $16.71 million | Fiscal year 2023: $9.69 million | Fiscal year 2022: $11.83 million | Fiscal year 2021: $24.36 million | Fiscal year 2020: $13.99 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: